Illumina Body Map 2
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TCF21 | hg19_v2_chr6_+_134210243_134210276 | 0.02 | 9.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_45826125 Show fit | 5.92 |
ENST00000221476.3
|
creatine kinase, muscle |
|
chr11_+_1944054 Show fit | 4.65 |
ENST00000397301.1
ENST00000397304.2 ENST00000446240.1 |
troponin T type 3 (skeletal, fast) |
|
chr17_+_45286387 Show fit | 3.72 |
ENST00000572316.1
ENST00000354968.1 ENST00000576874.1 ENST00000536623.2 |
myosin, light chain 4, alkali; atrial, embryonic |
|
chr1_+_171154347 Show fit | 3.47 |
ENST00000209929.7
ENST00000441535.1 |
flavin containing monooxygenase 2 (non-functional) |
|
chr16_-_31439735 Show fit | 3.16 |
ENST00000287490.4
|
cytochrome c oxidase subunit VIa polypeptide 2 |
|
chr3_+_8775466 Show fit | 2.94 |
ENST00000343849.2
ENST00000397368.2 |
caveolin 3 |
|
chr17_+_4487294 Show fit | 2.81 |
ENST00000338859.4
|
smoothelin-like 2 |
|
chr3_+_148583043 Show fit | 2.73 |
ENST00000296046.3
|
carboxypeptidase A3 (mast cell) |
|
chr8_+_86351056 Show fit | 2.63 |
ENST00000285381.2
|
carbonic anhydrase III, muscle specific |
|
chr2_-_152590946 Show fit | 2.63 |
ENST00000172853.10
|
nebulin |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 12.5 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.4 | 10.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.7 | 6.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.8 | 6.4 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.3 | 5.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 4.0 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.1 | 3.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.4 | 3.1 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.4 | 2.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 2.7 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 19.5 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 12.3 | GO:0031672 | A band(GO:0031672) |
0.3 | 6.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 4.6 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 3.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 3.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 3.2 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 3.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 2.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 2.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 22.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.8 | 7.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.2 | 6.2 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.6 | 5.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 5.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 5.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.2 | 4.6 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 4.2 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 4.1 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 3.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 5.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 3.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 3.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 3.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 3.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 3.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 2.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 2.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 2.3 | PID ENDOTHELIN PATHWAY | Endothelins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 16.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 7.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 3.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 3.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 2.8 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 2.6 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 2.2 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 2.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 2.0 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |